Company Filing History:
4 out of 1,830 
2 out of 258 
1 out of 36 
Years Active: 2016-2023
Title: Sibylle Hess: Innovator in Biomarker Research
Introduction
Sibylle Hess is a prominent inventor based in Frankfurt am Main, Germany. She has made significant contributions to the field of biomarker research, particularly in relation to metformin treatment. With a total of 4 patents, her work has the potential to impact patient care and treatment methodologies.
Latest Patents
One of her latest patents focuses on the use of growth differentiation factor 15 (GDF15) as a biomarker for metformin. This invention outlines methods for identifying patients who may benefit from metformin treatment based on their GDF15 levels. It also includes approaches for adapting metformin dosages and treating patients at risk of developing related diseases. The patent emphasizes the importance of GDF15 in determining treatment efficacy and provides kits for identifying suitable patients for metformin therapy.
Career Highlights
Sibylle has worked with notable organizations such as Sanofi-Aventis Deutschland GmbH and McMaster University. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Throughout her career, Sibylle has collaborated with esteemed colleagues, including Thorsten Sadowski and Hertzel Gerstein. These partnerships have enriched her research and expanded the impact of her innovations.
Conclusion
Sibylle Hess is a trailblazer in the realm of biomarker research, particularly concerning metformin treatment. Her patents and collaborations reflect her commitment to advancing medical science and improving patient outcomes.